News Sanofi Nasdaq

Equities

GCVRZ

US80105N1138

Delayed Nasdaq Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		+0.18%	+1.27%

05:41pm	European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading	MT
05:37pm	SANOFI : JP Morgan sticks Neutral	ZD

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading	11:41am	MT
SANOFI : JP Morgan sticks Neutral	11:37am	ZD
CAC40: starts the week on the right foot, approaches 7700pts	04:52am	CF
Sanofi: new Director of Group Corporate Affairs	Jun. 21	CF
Press Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive Committee	Jun. 21	GL
Sanofi Appoints Audrey Duval Derveloy as Executive Vice President, Global Head of Corporate Affairs and Member of its Executive Committee, Effective July 1, 2024	Jun. 21	CI
List of Companies That Allegedly Left Nigeria Under Tinubu's Presidency Is Not Accurate	Jun. 21	AQ
Sanofi: new positive data in hemophilia	Jun. 21	CF
US FDA Accepts Sanofi's New Drug Application for Hemophilia Treatment Fitusiran	Jun. 21	MT
Press Release: ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran	Jun. 21	GL
Sanofi to Present New Data from its Hemophilia Portfolio at the 32nd Congress of the International Society on Thrombosis and Haemostasis	Jun. 21	CI
Cybersecurity firm Semperis raises $125 mln from JP Morgan, Hercules Capital	Jun. 20	RE
France’s Sanofi Partners with South Africa’s Biovac for Polio Vaccine Initiative	Jun. 20	MT
Sanofi: partnership with Biovac against polio in Africa	Jun. 20	CF
Press Release: Sanofi and Biovac spearhead polio vaccine manufacturing capabilities in Africa	Jun. 20	GL
CAC40: falls below 7,600 pts in absence of Wall Street	Jun. 19	CF
Jasper Therapeutics, Inc. Announces Board Changes	Jun. 19	CI
INNATE PHARMA SHARES UPDATED RESULTS FROM THE SANOFI DEVELOPED BLOOD CANCER PHASE SAR443579/IPH6101 TRIAL	Jun. 18	AQ
Belharra Therapeutics, Inc. Announces Strategic Collaboration with Sanofi to Advance Discovery of Novel Small Molecule Therapeutics for Immunological Diseases	Jun. 18	CI
US FDA approves Merck's pneumococcal vaccine for adults	Jun. 17	RE